Skip to content

Suicide Risk Scale and Distress Intervention for the Patients With Chronic Medical Illness or Physical Disabilities

Development of a Suicide Risk Scale and Distress Intervention for the Patients With Chronic Medical Illness or Physical Disabilities

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04441060
Enrollment
15
Registered
2020-06-22
Start date
2019-04-29
Completion date
2022-07-30
Last updated
2024-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Illnesses, Physical Disability

Brief summary

The aims of this study are developments of distress intervention and a suicidal risk scale for the patients with chronic medical illness or physical disabilities. To do these things, four times of interview & completion of self-report scale will be done, and newly developed distress intervention will be simulated to subject group and control group.

Detailed description

The aims of this study are developments of distress intervention and a suicidal risk scale for the patients with chronic medical illness or physical disabilities. To achieve the aims, multidisciplinary team is organized such as doctors of internal medicine, rehabilitative medicine, psychiatrist specialized in psychosomatics, psychologist, nurse, social worker and researchers. Before developing the intervention and scale, review of literature about intervention, suicide, management system of chronic illness, several scales and others are done. Also, qualitative interview and self report scale with those patients are done to figure out what bothers them most, how they feel, and what kind of help they need. Based on collected data, means of intervention is carefully selected and further review of literature is proceeded. Also, questions which describe patients' feeling, discomfort, and need are made. Moreover, modified management system of chronic illness is planned to develop to link between those who need help among patients and multidisciplinary team members. Once, the intervention is developed, subject group and control group are recruited in stroke patients, and the intervention is simulated. The change of distress is measured before and after the intervention, and 1 month later the intervention is finished with several tools such as WHOQOL-BREF, Perceived Stress Scale, Rosenberg Self-Esteem Scale, Acceptance of Disability Scale, Participation Scale, Pain Belief & Perception Inventory, Insomnia Severity Index, FACIT-Fatigue, Hospital Anxiety and Depression Scale, digit span, trail making test, stroop test, verbal fluency test. Also, newly developed questions and other scales are performed among patients to determine whether the newly developed questions are appropriate and how well they reflect their difficulties and feelings. After selecting the appropriate questions, the revised version will be tested by the patients twice in a different time frame. If the revised version is appraised appropriate, it will be distributed as a cell phone application.

Interventions

OTHERDistress intervention (CBT & Mindfulness-based program)

Distress intervention is not fully developed yet, but we are working on the development of distress intervention based on CBT & Mindfulness-based program.

Sponsors

Seoul National University Hospital
Lead SponsorOTHER
Pusan National University
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
19 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients with chronic illness or physical disabilities (Heart failure, Chronic kidney disease, Stroke patients)

Exclusion criteria

* Patients who have other severe illness such as cancer, severe memory impairment or intellectual disabilities and others

Design outcomes

Primary

MeasureTime frameDescription
Quality of life: World Health Organization's quality of life instrument -short version (WHOQOL-BREF)baseline, within a week after the end of the full course of intervention, and 1 month later after the intervention is finishedQuality of life was assessed three times using the World Health Organization's quality of life instrument - short version (WHOQOL-BREF); before and after the intervention, and 1 month later after the intervention is finished. The amount of quality of life change will be one of the primary outcomes.
Stress: Perceived Stress Scale (PSS-10)baseline, within a week after the end of the full course of intervention, and 1 month later after the intervention is finishedStress was assessed three times using Perceived Stress Scale (PSS-10); before and after the intervention, and 1 month later after the intervention is finished. The amount of Stress change will be one of the primary outcomes.
Resilience: Connor-Davidson Resilience Scale (CDRS)baseline, within a week after the end of the full course of intervention, and 1 month later after the intervention is finishedResilience was assessed three times using Connor-Davidson Resilience Scale (CDRS); before and after the intervention, and 1 month later after the intervention is finished. The amount of resilience change will be one of the primary outcomes.
Self-esteem: Rosenberg Self-Esteem Scalebaseline, within a week after the end of the full course of intervention, and 1 month later after the intervention is finishedSelf-esteem was assessed three times using Rosenberg Self-Esteem Scale; before and after the intervention, and 1 month later after the intervention is finished. The amount of Self-esteem change will be one of the primary outcomes.
Acceptance of disability: Acceptance of Disability Scalebaseline, within a week after the end of the full course of intervention, and 1 month later after the intervention is finishedAcceptance of disability was assessed three times using Acceptance of Disability Scale; before and after the intervention, and 1 month later after the intervention is finished. The amount of acceptance of disability change will be one of the primary outcomes.
Social participation: Participation Scalebaseline, within a week after the end of the full course of intervention, and 1 month later after the intervention is finishedSocial participation was assessed three times using Participation Scale; before and after the intervention, and 1 month later after the intervention is finished. The amount of Social participation change will be one of the primary outcomes.
Pain: Pain belief & Perception inventory (PBPI)baseline, within a week after the end of the full course of intervention, and 1 month later after the intervention is finishedPain was assessed three times using Pain belief & Perception inventory (PBPI); before and after the intervention, and 1 month later after the intervention is finished. The amount of pain change will be one of the primary outcomes.
Insomnia: Insomnia Severity Index (ISI)baseline, within a week after the end of the full course of intervention, and 1 month later after the intervention is finishedInsomnia was assessed three times using Insomnia Severity Index (ISI); before and after the intervention, and 1 month later after the intervention is finished. The amount of Insomnia change will be one of the primary outcomes.
Fatigue: FACIT-Fatiguebaseline, within a week after the end of the full course of intervention, and 1 month later after the intervention is finishedFatigue was assessed three times using FACIT-Fatigue; before and after the intervention, and 1 month later after the intervention is finished. The amount of fatigue change will be one of the primary outcomes.
Depression, Anxiety: Hospital Anxiety and Depression Scalebaseline, within a week after the end of the full course of intervention, and 1 month later after the intervention is finishedDepression and anxiety was assessed three times using Hospital Anxiety and Depression Scale; before and after the intervention, and 1 month later after the intervention is finished. The amount of depression and anxiety change will be one of the primary outcomes. The 14-item Hospital Anxiety and Depression Scale comprises two subscales assessing anxiety and depression. Participants were asked to rate each item on a 4- point Likert scale (0-3); subscale scores ranged from 0 to 21. A cutoff score of 8 was applied to define clinical level of anxiety and depression.
Attention: Digit Span Testbaseline, within a week after the end of the full course of intervention, and 1 month later after the intervention is finishedAttention was assessed three times using the Digit Span Test; before and after the intervention, and 1 month later after the intervention is finished. The Digit Span test is a neuropsychological test in most common use for measuring attention-concentration and working memory. The amount of Digit Span Test result (percentile score) change will be one of the primary outcomes.
Attention: Trail Making Testbaseline, within a week after the end of the full course of intervention, and 1 month later after the intervention is finishedAttention was assessed three times using the Trail Making Test; before and after the intervention, and 1 month later after the intervention is finished. The Trail Making Test is a widely used neuropsychological measure that is known as a test of psychomotor speed, attention, sequencing, mental flexibility. The amount of Trail Making Test result (time to complete test) change will be one of the primary outcomes.
Attention: Stoop Color-Word Testbaseline, within a week after the end of the full course of intervention, and 1 month later after the intervention is finishedAttention was assessed three times using the Stoop Color-Word Test; before and after the intervention, and 1 month later after the intervention is finished. The Stroop color word test is useful to examines the frontal lobe function of selective attention and inhibition. The amount of Stoop Color-Word Test results (Time taken to perform, number performed correctly, number of errors) change will be one of the primary outcomes.
Suicide risk : Korea-Suicide Risk Scale (the name can be changed later)through study completion, an average of 1 yearSuicide risk scale will be developed and compared with other known tools. The scale has no definite name yet, but it can be called as Korea-Suicide Risk Scale for now. A score will be reported on a scale, the higher score, the severe the suicidal risk. About 90 questions are developed for the scale, and out of them, meaningful questions will be selected through large-scale interview & comparison with other scales about suicide during the study. We are not sure how many questions are selected by now, so the minimum or maximum score cannot be decided so far. Though, the questions have 4 point scale from 0 to 3.

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026